Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervix Uteri | 5 | 2008 | 27 | 1.120 |
Why?
|
| Wetlands | 4 | 2019 | 4 | 0.840 |
Why?
|
| Spinal Cord | 13 | 2006 | 130 | 0.750 |
Why?
|
| Ipomoea batatas | 1 | 2019 | 1 | 0.710 |
Why?
|
| Starch | 1 | 2019 | 8 | 0.710 |
Why?
|
| Morphine | 5 | 2008 | 44 | 0.700 |
Why?
|
| Pain | 5 | 2010 | 288 | 0.670 |
Why?
|
| Neurons, Afferent | 3 | 2008 | 55 | 0.580 |
Why?
|
| Analgesics, Opioid | 6 | 2015 | 231 | 0.580 |
Why?
|
| Estrogens | 3 | 2007 | 167 | 0.560 |
Why?
|
| TRPV Cation Channels | 2 | 2007 | 22 | 0.560 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2015 | 745 | 0.550 |
Why?
|
| Clonidine | 10 | 2004 | 61 | 0.510 |
Why?
|
| Rats | 15 | 2015 | 1596 | 0.480 |
Why?
|
| Rivers | 2 | 2014 | 4 | 0.460 |
Why?
|
| Injections, Spinal | 15 | 2015 | 108 | 0.450 |
Why?
|
| Poaceae | 1 | 2012 | 2 | 0.430 |
Why?
|
| Plant Leaves | 1 | 2012 | 6 | 0.430 |
Why?
|
| Adrenergic alpha-Agonists | 7 | 2004 | 42 | 0.430 |
Why?
|
| Physical Stimulation | 7 | 2015 | 84 | 0.380 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2015 | 40 | 0.360 |
Why?
|
| Hyperalgesia | 3 | 2015 | 78 | 0.360 |
Why?
|
| Animals | 31 | 2015 | 7466 | 0.350 |
Why?
|
| Pain Measurement | 7 | 2015 | 351 | 0.340 |
Why?
|
| Ganglia, Spinal | 2 | 2008 | 65 | 0.330 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 179 | 0.320 |
Why?
|
| Labor, Obstetric | 2 | 2008 | 36 | 0.320 |
Why?
|
| Labor Pain | 1 | 2008 | 8 | 0.320 |
Why?
|
| Uterus | 3 | 2004 | 93 | 0.300 |
Why?
|
| Models, Animal | 1 | 2008 | 164 | 0.300 |
Why?
|
| Analgesics | 3 | 2004 | 109 | 0.290 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 20 | 0.290 |
Why?
|
| Behavior, Animal | 2 | 2008 | 250 | 0.280 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2006 | 8 | 0.270 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 10 | 0.270 |
Why?
|
| Somatostatin | 1 | 2006 | 11 | 0.270 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2006 | 47 | 0.270 |
Why?
|
| Ketorolac | 3 | 2015 | 24 | 0.270 |
Why?
|
| Female | 30 | 2015 | 19953 | 0.260 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2005 | 9 | 0.250 |
Why?
|
| Neostigmine | 6 | 1996 | 16 | 0.250 |
Why?
|
| China | 5 | 2020 | 50 | 0.240 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2004 | 4 | 0.240 |
Why?
|
| Cyclopropanes | 1 | 2004 | 19 | 0.240 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1017 | 0.240 |
Why?
|
| Genes, fos | 1 | 2003 | 4 | 0.230 |
Why?
|
| Posterior Horn Cells | 1 | 2003 | 11 | 0.220 |
Why?
|
| Piperidines | 3 | 2015 | 117 | 0.220 |
Why?
|
| Temperature | 2 | 2019 | 55 | 0.200 |
Why?
|
| Hemodynamics | 6 | 1999 | 155 | 0.200 |
Why?
|
| Acetylcholine | 7 | 2001 | 47 | 0.190 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2000 | 10 | 0.190 |
Why?
|
| Analgesia, Epidural | 3 | 1996 | 51 | 0.190 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 494 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2000 | 68 | 0.180 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 17 | 0.180 |
Why?
|
| Amylopectin | 1 | 2019 | 1 | 0.180 |
Why?
|
| Amylose | 1 | 2019 | 1 | 0.180 |
Why?
|
| Chromatography, Gel | 1 | 2019 | 9 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 98 | 0.170 |
Why?
|
| Nitrogen | 1 | 2019 | 10 | 0.170 |
Why?
|
| Hindlimb | 3 | 2008 | 54 | 0.170 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 71 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 629 | 0.160 |
Why?
|
| Cytokine-Induced Killer Cells | 1 | 2018 | 1 | 0.160 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hot Temperature | 4 | 2015 | 71 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 99 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 103 | 0.160 |
Why?
|
| Nitric Oxide | 5 | 1997 | 112 | 0.160 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 532 | 0.150 |
Why?
|
| Alfentanil | 1 | 1997 | 1 | 0.150 |
Why?
|
| Amitriptyline | 1 | 1997 | 6 | 0.150 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1997 | 6 | 0.150 |
Why?
|
| Sheep | 15 | 1999 | 233 | 0.150 |
Why?
|
| Skin | 2 | 2018 | 210 | 0.140 |
Why?
|
| Afferent Pathways | 2 | 2008 | 23 | 0.140 |
Why?
|
| Ephedrine | 2 | 1996 | 3 | 0.140 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1996 | 31 | 0.140 |
Why?
|
| Norepinephrine | 4 | 1997 | 77 | 0.130 |
Why?
|
| Capsaicin | 3 | 2010 | 24 | 0.130 |
Why?
|
| Certification | 1 | 2016 | 27 | 0.130 |
Why?
|
| Conservation of Natural Resources | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 6 | 0.130 |
Why?
|
| Umbilical Cord | 1 | 2015 | 8 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2016 | 123 | 0.130 |
Why?
|
| Anesthesiology | 1 | 2016 | 49 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2015 | 13 | 0.120 |
Why?
|
| Oxytocin | 1 | 2015 | 27 | 0.120 |
Why?
|
| Adult | 10 | 2018 | 9366 | 0.120 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 28 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 37 | 0.120 |
Why?
|
| Pregnancy | 6 | 2008 | 994 | 0.120 |
Why?
|
| Seasons | 1 | 2014 | 87 | 0.110 |
Why?
|
| Metaraminol | 2 | 1996 | 2 | 0.110 |
Why?
|
| Catheterization | 2 | 2004 | 58 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 185 | 0.110 |
Why?
|
| Pregnancy, Animal | 2 | 2008 | 19 | 0.110 |
Why?
|
| Naloxone | 2 | 2012 | 26 | 0.110 |
Why?
|
| Endothelium, Vascular | 3 | 1996 | 156 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 182 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1994 | 63 | 0.110 |
Why?
|
| Tidal Waves | 1 | 2012 | 1 | 0.110 |
Why?
|
| Psoriasis | 1 | 2018 | 360 | 0.110 |
Why?
|
| Flowers | 1 | 2012 | 2 | 0.110 |
Why?
|
| Water Microbiology | 1 | 2012 | 6 | 0.110 |
Why?
|
| Opioid Peptides | 1 | 2012 | 14 | 0.100 |
Why?
|
| Uterine Contraction | 1 | 1992 | 7 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 253 | 0.100 |
Why?
|
| Nociceptors | 1 | 2012 | 39 | 0.100 |
Why?
|
| Humans | 16 | 2020 | 32024 | 0.100 |
Why?
|
| Action Potentials | 3 | 2008 | 178 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 4 | 1996 | 35 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2015 | 656 | 0.080 |
Why?
|
| Nesting Behavior | 1 | 2008 | 3 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2008 | 22 | 0.080 |
Why?
|
| Male | 13 | 2018 | 19195 | 0.080 |
Why?
|
| Injections, Intravenous | 3 | 2004 | 76 | 0.080 |
Why?
|
| Analgesia, Obstetrical | 1 | 2008 | 47 | 0.080 |
Why?
|
| Stimulation, Chemical | 3 | 2015 | 13 | 0.070 |
Why?
|
| Ecosystem | 2 | 2019 | 6 | 0.070 |
Why?
|
| Imidazoles | 5 | 1999 | 91 | 0.070 |
Why?
|
| Drug Interactions | 2 | 1997 | 79 | 0.070 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 116 | 0.070 |
Why?
|
| Cyclooxygenase 1 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Time Factors | 2 | 2008 | 2152 | 0.070 |
Why?
|
| Analgesia | 2 | 1996 | 29 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2006 | 82 | 0.060 |
Why?
|
| Neurons | 1 | 2008 | 409 | 0.060 |
Why?
|
| Rectum | 1 | 2004 | 17 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 36 | 0.060 |
Why?
|
| Electromyography | 1 | 2004 | 59 | 0.060 |
Why?
|
| Colon | 1 | 2004 | 52 | 0.060 |
Why?
|
| Nerve Block | 1 | 2004 | 50 | 0.060 |
Why?
|
| Succinate Dehydrogenase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2004 | 149 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 31 | 0.060 |
Why?
|
| Dioxanes | 5 | 1996 | 6 | 0.050 |
Why?
|
| Idazoxan | 5 | 1996 | 10 | 0.050 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 1996 | 24 | 0.050 |
Why?
|
| Cholinergic Fibers | 1 | 2001 | 7 | 0.050 |
Why?
|
| Young Adult | 3 | 2015 | 2615 | 0.050 |
Why?
|
| Diencephalon | 1 | 2000 | 1 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 3 | 1996 | 33 | 0.050 |
Why?
|
| Seizures | 1 | 2000 | 64 | 0.040 |
Why?
|
| Geologic Sediments | 1 | 2019 | 2 | 0.040 |
Why?
|
| Climate | 1 | 2019 | 3 | 0.040 |
Why?
|
| Biomass | 1 | 2019 | 3 | 0.040 |
Why?
|
| Indans | 1 | 1999 | 31 | 0.040 |
Why?
|
| Carbon | 1 | 2019 | 12 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 103 | 0.040 |
Why?
|
| Nitrates | 1 | 2019 | 27 | 0.040 |
Why?
|
| Neurotransmitter Agents | 2 | 1997 | 26 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 277 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 80 | 0.040 |
Why?
|
| Receptors, Muscarinic | 2 | 1995 | 9 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 945 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 1997 | 6 | 0.040 |
Why?
|
| Injections, Epidural | 1 | 1996 | 9 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 1996 | 13 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 544 | 0.030 |
Why?
|
| Potassium Chloride | 2 | 1996 | 5 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1996 | 2 | 0.030 |
Why?
|
| Nausea | 1 | 1996 | 53 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 11868 | 0.030 |
Why?
|
| Sympathomimetics | 1 | 1996 | 4 | 0.030 |
Why?
|
| Pain Threshold | 2 | 2008 | 92 | 0.030 |
Why?
|
| Vasoconstriction | 2 | 1996 | 41 | 0.030 |
Why?
|
| Narcotic Antagonists | 2 | 2012 | 39 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 63 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 24 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 31 | 0.030 |
Why?
|
| Environmental Pollution | 1 | 2015 | 5 | 0.030 |
Why?
|
| Epidermis | 1 | 2015 | 30 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 98 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 147 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 765 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 99 | 0.030 |
Why?
|
| Regional Blood Flow | 3 | 2001 | 86 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 163 | 0.030 |
Why?
|
| Photosynthesis | 1 | 2014 | 1 | 0.030 |
Why?
|
| Wind | 1 | 2014 | 2 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1994 | 12 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 292 | 0.030 |
Why?
|
| Age Factors | 2 | 2008 | 1194 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 228 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 526 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 1993 | 22 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2016 | 333 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 1992 | 3 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2015 | 833 | 0.030 |
Why?
|
| Hypotension | 1 | 1993 | 47 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 468 | 0.030 |
Why?
|
| Shock | 1 | 1992 | 30 | 0.030 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 31 | 0.030 |
Why?
|
| Fetus | 1 | 1992 | 86 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 92 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1996 | 845 | 0.020 |
Why?
|
| Carbachol | 1 | 1991 | 5 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3317 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 51 | 0.020 |
Why?
|
| Microdialysis | 2 | 2001 | 34 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2280 | 0.020 |
Why?
|
| Hypogastric Plexus | 1 | 2008 | 8 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 71 | 0.020 |
Why?
|
| United States | 1 | 2016 | 3938 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2006 | 67 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 197 | 0.020 |
Why?
|
| Pirenzepine | 2 | 1995 | 2 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 10340 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2006 | 508 | 0.010 |
Why?
|
| Bupivacaine | 1 | 2004 | 50 | 0.010 |
Why?
|
| Anesthesia | 1 | 2004 | 64 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 79 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 3526 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2001 | 23 | 0.010 |
Why?
|
| Fluorine Radioisotopes | 1 | 2001 | 19 | 0.010 |
Why?
|
| Fluorobenzenes | 1 | 2001 | 19 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1999 | 17 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2001 | 285 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 4 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 496 | 0.010 |
Why?
|
| Femoral Nerve | 1 | 1996 | 6 | 0.010 |
Why?
|
| Microchemistry | 1 | 1996 | 5 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 18 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1996 | 8 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 17 | 0.010 |
Why?
|
| Dialysis | 1 | 1996 | 3 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 49 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 93 | 0.010 |
Why?
|
| Fentanyl | 1 | 1996 | 33 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 67 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1996 | 104 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 165 | 0.010 |
Why?
|
| Respiration | 1 | 1995 | 27 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1995 | 95 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 6 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 4 | 0.010 |
Why?
|
| Medetomidine | 1 | 1993 | 2 | 0.010 |
Why?
|
| Aorta | 1 | 1994 | 125 | 0.010 |
Why?
|
| Dopamine | 1 | 1996 | 232 | 0.010 |
Why?
|
| Basilar Artery | 1 | 1992 | 9 | 0.010 |
Why?
|
| Catecholamines | 1 | 1992 | 18 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1992 | 50 | 0.010 |
Why?
|